NCT05142592 2025-09-24
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
Nanjing Immunophage Biotech Co., Ltd
Phase 1/2 Recruiting
Nanjing Immunophage Biotech Co., Ltd
Anhui Provincial Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ReHeva Biosciences,Inc.
McGill University Health Centre/Research Institute of the McGill University Health Centre